Basit öğe kaydını göster

dc.contributor.authorGokturk, Bahar
dc.contributor.authorReisli, Ismail
dc.date.accessioned2019-06-15T08:44:37Z
dc.date.available2019-06-15T08:44:37Z
dc.date.issued2016
dc.identifier.issn1308-9234
dc.identifier.urihttp://eds.a.ebscohost.com/eds/pdfviewer/pdfviewer?vid=0&sid=fd7e570a-7199-47b3-8398-9903e40c35ab%40sdc-v-sessmgr01
dc.identifier.urihttp://hdl.handle.net/11727/3557
dc.description.abstractDiGeorge syndrome, which is caused by abnormal development and migration of neural crest cells, is the most common microdeletion syndrome. The phenotype is variable due to the existence of more than 35 genes in the typical deletion region. However, the genotypephenotype correlation is very weak in this patient group. Every patient with facial dysmorphism, delay in developmental milestones and macrothrombocytopenia should be questioned for the other specific findings of DGS, and tested if needed. All findings do not have to be together to make the diagnosis. It should be known that patients experience different problems at different stages of their lives, and genetic counseling should be provided to the patients and their families. Our aim in this review was to provide detailed information and raise awareness about DGS as it is common but rarely diagnosed, and presents many difficulties during follow-up.en_US
dc.language.isoturen_US
dc.relation.isversionof10.21911/aai.5013en_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectDiGeorge syndromeen_US
dc.subjectHypoparathyroidismen_US
dc.subjectConotruncal-cardiac defecten_US
dc.subjectMacrothrombocytopeniaen_US
dc.titleDiGeorge Syndromeen_US
dc.typereviewen_US
dc.relation.journalASIM ALLERJI IMMUNOLOJIen_US
dc.identifier.volume14en_US
dc.identifier.issue3en_US
dc.identifier.startpage129en_US
dc.identifier.endpage142en_US
dc.identifier.wos000404965600004en_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster